CHICAGO, July 2, 2024 /PRNewswire/ -- The
global digital PCR (dPCR) and real-time PCR (qPCR) market is
set to expand significantly, with projections indicating growth
from USD 10.0 billion in 2024 to
USD 14.8 billion by 2029 at a CAGR of
8.1% during the forecast period of 2024 to 2029, driven by factors
such as increasing incidences of infectious diseases and genetic
disorders, advancements in PCR technologies, and the rising demand
for point-of-care diagnostics. However, challenges like lengthy
procedures and accuracy issues hinder market growth. Opportunities
lie in the integration of PCR technologies in personalized
medicine, particularly in drug development through companion
diagnostics. Despite competition from alternative technologies like
NGS and immunoassays, the market's ecosystem includes key entities
such as major manufacturers (e.g., Danaher Corporation, Thermo
Fisher Scientific), research institutes, hospitals, and diagnostic
laboratories, positioning North
America as the leading regional market.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204
Browse in-depth TOC on "Digital PCR and Real-Time PCR
Market"
907 - Tables
58 - Figures
632 -
Pages
Key Players in the Market: Danaher Corporation
Danaher Corporation (US) holds a prominent position in the
global digital PCR (dPCR) and real-time PCR (qPCR) markets, owing
to its innovative technologies and strategic acquisitions. The
company's portfolio includes high-performance instruments like the
QuantStudio and QX200 Droplet Digital PCR Systems, known for their
precision and reliability in nucleic acid quantification. By
investing heavily in research and development, Danaher continuously
introduces state-of-the-art solutions that meet evolving clinical
and research laboratory needs. Leveraging a strong global presence
and robust distribution network, Danaher ensures broad
accessibility to its advanced products, thus maintaining
competitiveness and fostering market growth.
Innovative Offerings: F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. (Switzerland) is another major player in the
digital PCR (dPCR) and real-time PCR (qPCR) market, renowned for
its commitment to innovation. The company's LightCycler and Cobas
platforms set industry standards with their precision, reliability,
and user-friendly interfaces. Roche's digital PCR solutions excel
in accurately quantifying nucleic acids, even at low
concentrations, while the recently launched LightCycler PRO System
underscores Roche's ongoing advancements in qPCR technology. This
system, designed to meet clinical diagnostic and research demands,
features enhanced temperature uniformity, improved software
algorithms, and a user-friendly interface, positioning Roche
competitively in the market.
Strategic Focus: Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. (US) plays a pivotal role in the
Digital PCR (dPCR) and Real-time PCR (qPCR) market, catering to
diverse end-users including hospitals, diagnostic laboratories,
CROs, CDMOs, and pharmaceutical and biopharmaceutical companies.
The company enhances its market presence through strategic
initiatives such as product launches and collaborations. Notably,
Thermo Fisher's TaqPath Real-time
PCR kits, launched in February 2023
for infectious disease detection in India, highlight its commitment to expanding
diagnostic capabilities. Additionally, research partnerships with
leading organizations strengthen Thermo
Fisher's research and product development efforts in dPCR
and qPCR technologies, reinforcing its competitive edge in the
market.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=174151204
Segmentation Insights: Products and Applications
The market is segmented into reagents and consumables, and
instruments, with the former accounting for the largest share and
projected to grow at the highest CAGR. This segment benefits from
frequent replacement needs and broad application range. In terms of
application, clinical applications dominate due to the growing use
of qPCR in disease diagnosis and the technological advantages of
dPCR and qPCR in precision and absolute quantification of target
molecules.
End-User Landscape
End-user segmentation includes hospitals and diagnostic
laboratories, academic and research institutes, pharmaceutical and
biotechnology companies, CROs and CDMOs, forensic laboratories, and
others. Hospitals and diagnostic laboratories lead the market,
driven by increased adoption of dPCR and qPCR technologies for
efficient disease diagnosis and expanding healthcare
infrastructure, particularly in emerging markets.
Regional Insights
Regionally, North America leads
the market, followed by Europe and
the Asia Pacific. The Asia Pacific region shows the highest growth
potential, supported by increasing pharmaceutical R&D
activities, demand for novel dPCR and qPCR products, investments by
biopharmaceutical companies, and government support for
genomics-based research.
For more information, inquire now! Inquire Now
Related Reports:
Next Generation Sequencing Market
In Vitro Diagnostics Market
Life Science Instrumentation Market
Flow Cytometry Market
Sepsis Diagnostics Market
Get access to the latest updates on Digital PCR (dPCR) and
Real-time PCR (qPCR) Companies and Digital PCR (dPCR)
and Real-time PCR (qPCR) Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us
on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan
Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo:
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/global-digital-pcr-and-real-time-pcr-market-dynamics-forecasted-growth-to-usd-14-8-billion--marketsandmarkets-302187859.html